Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.15 USD | +5.00% |
|
+17.98% | -2.78% |
Business Summary
Number of employees: 66
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pathogen-specific Bacteriophage Therapeutics
100.0
%
| 6 | 100.0 % | 5 | 100.0 % | -17.77% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Australia
100.0
%
| 6 | 100.0 % | 5 | 100.0 % | -17.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Richard Rychlik
DFI | Director of Finance/CFO | 68 | 23-09-04 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 20-10-25 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 20-02-11 | |
Joseph Patti
BRD | Director/Board Member | 60 | 19-05-08 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 21-03-31 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 20-02-11 |
Robin Kramer
CHM | Chairman | 58 | 20-12-07 |
Todd Peterson
BRD | Director/Board Member | 66 | 19-10-09 |
Deborah Birx
CEO | Chief Executive Officer | 68 | 23-07-10 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,154,617 | 10,736,770 ( 29.70 %) | 0 | 29.70 % |
Company contact information
![address Armata Pharmaceuticals, Inc.(ARMP)](https://cdn.zonebourse.com/static/address/58255995.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.78% | 114M | |
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- ARMP Stock
- Company Armata Pharmaceuticals, Inc.